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Summary
Mycolic acids are essential components of the mycobacterial cell wall. In this study, we show that a
gene encoding a reductase involved in the final step of mycolic acid biosynthesis can be deleted in
Mycobacterium smegmatis without affecting cell viability. Deletion of MSMEG4722 (ortholog of
Mycobacterium tuberculosis Rv2509) altered culture characteristics and antibiotic sensitivity. The
ΔMSMEG4722 strain synthesized α-alkyl, β-oxo intermediates of mycolic acids, which were found
esterified to cell wall arabinogalactan. While the precursors could not be isolated directly due to their
inherent instability during base treatment, their presence was established by prior reduction of the
β-oxo group by sodium borohydride. Interestingly, the mutant also accumulated unsaturated ketones,
similar to tuberculenone from M. tuberculosis, which were shunt products derived from spontaneous
decarboxylation of α-alkyl, β-oxo fatty acid precursors of mycolic acids.
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Introduction
Mycolic acids are a major and essential component of the lipid-rich cell envelope of the human
pathogen Mycobacterium tuberculosis and other related mycobacteria. Found either covalently
attached to the terminal arabinose residues of the mycolyl arabinogalactan-peptidoglycan
(mAGP) complex, or as the free glycolipids, trehalose monomycolate (TMM), trehalose
dimycolate (TDM), and glucose monomycolate (GMM), these α-alkyl, β-hydroxyl long-chain
fatty acids play an important role in reduced cell wall permeability (Brennan and Nikaido,
1995; Daffe and Draper, 1998; Gao et al., 2003; Jackson et al., 1999) and virulence (Bhatt
et al., 2007; Dubnau et al., 2000; Gao et al., 2003; Glickman et al., 2000; Rao et al., 2006) of
mycobacteria. In M. tuberculosis, a multifunctional type I fatty acid synthase (FAS-I)
synthesizes C16–18 and C24–26 fatty acids in a bimodal fashion. The former is then channeled
to a type-II, multienzyme complex called FAS-II, which, through its iterative reductive cycles,
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extends the acyl chain to long-chain meromycolic acids (C56–64) (Bloch, 1975, 1977; Brindley
et al., 1969; Peterson and Bloch, 1977). Finally, a polyketide synthase, Pks13, catalyzes the
Claisen condensation of a C26 fatty acid and a mero-acid to yield an α-alkyl, β-oxo acyl
intermediate, which in turn is reduced to form a mature mycolic acid (Gande et al., 2004;
Portevin et al., 2004) (Figure 1A). While earlier studies were focused on identifying genes
encoding “core” FAS-II enzymes, little was known about the final, post-Pks13 step of mycolic
acid biosynthesis: the reduction of the β-oxo group to a hydroxyl group leading to the formation
of the mycolic acid motif. Unlike in mycobacteria, genes encoding enzymes involved in the
biosynthesis of mycolic acids are nonessential in corynebacteria, facilitating the generation of
null mutants. Recently, Lea-Smith et al. (2007) generated a mutant of Corynebacterium
glutamicum NCgl2385 that had a slow-growth phenotype, and produced corynomycolate
precursors with a β-oxo group. In the same study, the authors also used bioinformatics to
identify Rv2509, the M. tuberculosis ortholog of NCgl2385, as a possible candidate for
reduction of the mycolic acid motif (Lea-Smith et al., 2007). Mycobacterium smegmatis has
often been used as a surrogate for M. tuberculosis when studying biosynthetic pathways. The
fast-growing, nonpathogenic M. smegmatis strain is particularly useful in studying cell wall
biosynthesis genes, since it can tolerate deletion of some genes that are essential in M.
tuberculosis (Amin et al., 2008; Escuyer et al., 2001). Moreover, while the two species differ
in mero-chain modifications, core enzymes involved in mycolate biosynthesis are
interchangeable (Brown et al., 2007; Parish et al., 2007). We thus chose to address the role of
Rv2509 in mycobacterial mycolic acid biosynthesis by generating a deletion mutant of
MSMEG4722, the M. smegmatis homolog of Rv2509.
Results
MSMEG4722 and Rv2509 Encode Proteins Structurally Similar to Short-Chain Reductases/
Dehydrogenases
Through the use of bioinformatics, Lea-Smith et al. (2007) identified M. tuberculosis Rv2509
as the homolog of NCgl2385, the C. glutamicum reductase involved in mycolic acid motif
formation. The closest match for Rv2509 in the M. smegmatis mc2155 genome was the putative
protein MSMEG4722 (Figure 1B). Both predicted proteins contained conserved active site
residues and residues for NAD/NADP binding (Figure 1B). Predictions of the three-
dimensional (3D) structures of proteins often give insights into potential catalytic properties.
We used the @TOME server to screen for known structures of proteins that were predicted to
be most closely related to Rv2509 (Douguet and Labesse, 2001). Predictions of E values from
TITO and 3D-PSSM servers (−121140 and 1.23e-02, respectively) strongly suggested that
1cyd (Mus musculus carbonyl reductase complexed with NADPH and 2-propanol) was the
closest match to Rv2709 (22% sequence identity). Through use of the 1cyd coordinates and
the FUGUE server (Shi et al., 2001), we generated an in silico 3D structure of Rv2509. The
predictions revealed similar 3D structural folds for 1cyd, Rv2509, and the Escherichia coli
fatty acid reductase, FabG (data not shown). Additionally, when the NADPH moiety from 1cyd
was superimposed in the predicted NADP-binding fold of Rv2509, the predicted distances
between the conserved residues and the cofactor showed a fit similar to that seen in 1cyd (data
not shown). These data suggest that Rv2509 was likely an NAD/NADP-dependent
mycobacterial reductase. As outlined above, the homologous M. smegmatis gene
MSMEG4722 was chosen for further analysis.
Deletion of MSMEG4722 in M. smegmatis mc2155 Alters Culture Characteristics and
Sensitivity to Antibiotics
In order to study the role of MSMEG4722 in mycolic acid motif formation, we deleted
MSMEG4722 in M. smegmatis mc2155 by specialized transduction (Bardarov et al., 2002)
(Figure 2A). The ability to generate a null mutant indicated that MSMEG4722 was not essential
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for the viability of M. smegmatis mc2155. Loss of MSMEG4722 had a remarkable effect on
the colony morphology of M. smegmatis mc2155 on tryptic soy broth (TSB) agar. While the
colonies of the parental, wild-type strain mc2155 were glossy, those of the mutant strain
ΔMSMEG4722 appeared to have a dry surface (Figure 2B). The change was more apparent
when the strains were grown on TSB agar supplemented with Tween-80. Unlike colonies of
the parental strain, mc2155, which had a smooth surface, colonies of ΔMSMEG4722 had an
irregular, convoluted surface (Figure 2B). The ΔMSMEG4722 mutant also showed a slightly
slower growth rate than the parental mc2155 strain (Figure 2C; the OD600 values at 24h
correspond to 2 × 108 and 107 colony forming units/ml for mc2155 and ΔMSMEG4722,
respectively). This was not surprising, as a similar growth defect was observed when the
homologous gene was deleted in C. glutamicum, and a genome-wide transposon screen
predicted that the loss of the homologous gene in M. tuberculosis would result in a slow-growth
phenotype (Lea-Smith et al., 2007; Sassetti et al., 2003). Additionally, when grown in Luria-
Bertani broth (LB), the mutant showed an increased sensitivity to the lipophilic antibiotic
rifampicin (minimum inhibitory concentrations [MIC] = 0.125 μg/ml) as compared with the
parental strain mc2155 (MIC = 16 μg/ml), but not to hydrophilic antibiotics, such as isoniazid
and ethambutol. Wild-type characteristics were restored on complementation of the
ΔMSMEG4722 mutant with plasmid-borne MSMEG4722, indicating that the observed
phenotypes in the mutant strain were solely due to the loss of MSMEG4722 (Figures 2B and
2C).
The ΔMSMEG4722 Mutant Failed to Synthesize Mature Mycolic Acids
The predicted role of MSMEG4722 in mycolic acid motif formation and the observed changes
in the colony morphology of the ΔMSMEG4722 mutant prompted us to examine mycolic acids
in the mutant strain. If MSMEG4722 was indeed the reductase catalyzing the conversion of
the post-Pks13, α-alkyl, β-oxo fatty acyl intermediate, then the ΔMSMEG4722 mutant would
be expected to accumulate this unreduced intermediate of mycolic acid biosynthesis
(Figure 1A). A standard procedure for release of mycolic acids from mycobacteria involves
base hydrolysis of cells with tetrabutyl ammonium hydroxide (TBAH). This is followed by
phase-transfer catalyzed derivatization with methyl iodide that results in the formation of
mycolic acid methyl esters (MAMEs) (Dobson et al., 1985), which are analyzed by thin-layer
chromatography (TLC). Following base treatment and derivatization, [14C]-labeled extracts
obtained from strains were analyzed by TLC. While α, α′ and epoxy MAMEs were present in
the parental mc2155 strain, all three species were missing in the extract from the
ΔMSMEG4722 strain (Figure 3A). Instead, the mutant strain showed the accumulation of a
product(s) with a higher retardation factor (Rf) migrating above the fatty acid methyl esters
(FAMEs). When extracts from the mutant strain were analyzed by 2D-Ag+-argentation TLC,
the rapidly migrating species resolved into multiple subspecies in the second, Ag+-containing
dimension, indicating the presence of multiple species differing in degrees of unsaturation
(Figure 3B). An identical result was obtained for extracts from delipidated cells that only
contain cell wall-bound mycolates (Figure 3A), indicating that the observed changes in
mycolate profiles applied to both total and specifically cell wall-bound mycolates.
Mycolic acid biosynthesis was restored in the mutant strain following complementation with
not only MSMEG4722, but also Rv2509, indicating that Rv2509 was a functional homolog of
MSMEG4722 in M. tuberculosis (strains ΔMSMEG4722-C and ΔMSMEG4722-CRv,
respectively; Figure 3A).
The ΔMSMEG4722 Mutant Accumulates Precursors of Mycolic Acids in the Cell Wall
The complete absence of α, α′ and epoxy MAMEs and the appearance of rapidly migrating
species in extracts of the ΔMSMEG4722 mutant suggest that these rapidly migrating species
may either be precursors of mycolates or decomposition products of precursors generated as
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a result of the extraction procedure. The latter seemed more likely, as base treatment of an
unreduced α-alkyl, β-oxo fatty acid precursor, containing two oxo groups in close proximity,
has been shown to result in the generation of a palmitone-like decomposition product in
corynebacteria (Walker et al., 1973). Such decomposition products would be expected to
migrate similarly to the rapidly migrating species that were observed in the extracts of the
mutant strain. To confirm whether unreduced precursors of α, α′ and epoxy mycolic acids were
present in the mutant strain, cells were pretreated with sodium borohydride (NaBH4). This
pretreatment has little effect on normal mycolates, but results in the reduction of the β-oxo
group in putative α-alkyl, β-oxo fatty acyl intermediates, resulting in the formation of α-alkyl,
β-hydroxy products, viz. mature mycolic acids. Thus, if the α-alkyl, β-oxo fatty acid precursors
of α, α′ and epoxy mycolic acids did exist in the mutant strain, pretreatment with NaBH4 would
be expected to convert these precursors into α, α′ and epoxy mycolic acids, and TLC analysis
of TBAH-treated, methylated extracts from NaBH4-pretreated ΔMSMEG4722 cells would
show the presence of α, α′ and epoxy MAMEs due to the prior reduction of the β-oxo group.
When extracts of NaBH4-pretreated cells were analyzed by TLC, species migrating with the
same Rf values as α, α′ and epoxy MAMEs were observed (Figure 3C). However, additional
MAMEs were also present in the extracts. Two closely migrating species had a very low Rf
value, and were detected in total mycolates strains from all strains (MAME-I; Figure 3C), while
another with an Rf value slightly greater than α-MAMEs was seen only in extracts from the
mutant strain (MAME-II; Figure 3C).
MAME-I corresponded in chromatographic migration to two hydroxylated artifacts,
characterized previously in acid methanolysates of mycobacteria having epoxy mycolates
(Minnikin et al., 1982). Similar hydroxylated artifacts would be expected by NaBH4 reduction
of the epoxy group in epoxy mycolates. Mass spectroscopic (MS) analysis confirmed these
findings with molecular sizes detected in all strains corresponding to those of α, α′, epoxy
MAMEs, and to the reduced, hydroxylated products of epoxy MAMEs (Table 1). Similar
results were obtained when the analyses were performed on delipidated cells, indicating that
the α-alkyl, β-oxo fatty acyl precursors of mycolates from M. smegmatis were esterified to the
AG in the cell wall (Figure 3C). However, in this case, only a single MAME-I hydroxylated
component was produced on NaBH4-reduction of the delipidated cells (Figure 3C).
The NaBH4-reduction of the β-oxo group, in a mycolate precursor, would result in two
diastereoisomers of MAMEs, which would migrate differently on TLC (Minnikin and Polgar,
1966). MAME-II, therefore, was likely to be a mycolate β-epimer and, on matrix-assisted laser
desorption ionization-time of flight/MS (MALDI-TOF/MS), the molecular size was found to
be identical to that of α-MAMES. Indeed, purified MAME-II comigrated with a known
standard for α-MAME β-epimer (data not shown). These results showed that the
ΔMSMEG4722 mutant, due to loss of mycolyl reductase function, failed to make mature
mycolic acids, and instead synthesized the α-alkyl, β-oxo fatty acyl precursors of α, α′ and
epoxy mycolates that were transported and subsequently esterified to the reducing termini of
the AG complex.
Lipid Analysis Revealed Accumulation of a Nonpolar Lipid in the ΔMSMEG4722 Mutant
Polar and nonpolar lipids labeled with [14C]-acetate were extracted from mc2155,
ΔMSMEG4722, and ΔMSMEG4722-C strains and analyzed by 2D-TLC (Dobson et al.,
1985). Interestingly, the lipids corresponding to TMM and TDM in mc2155 were replaced by
two lipids with slightly altered mobilities in the mutant strain (Figure 4A). Both lipids had a
slightly higher Rf value (Rf = 0.147 and Rf = 0.39) than parental TMM and TDM (Rf = 0.117
and Rf = 0.36) in direction 1. This altered mobility was likely due to esterification of the α-
alkyl, β-oxo mycolic acid precursors (instead of mature mycolic acids) to trehalose in the
mutant strain, as was observed in the C. glutamicum mutant (Lea-Smith et al., 2007).
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Furthermore, the mutant strain showed accumulation of a nonpolar species accompanied by a
total loss of free mycolic acids (Figures 4B and 4C). This lipid species, referred to as Lipid-Y,
did not stain with Dittmer-Lester reagent or with α-napthol-sulfuric acid, indicating the absence
of phosphate groups and carbohydrates (data not shown). Following purification by preparative
TLC, Lipid-Y was characterized by MALDI-TOF/MS and nuclear magnetic resonance (NMR)
(Figure 5). Three species of m/z 907.6, 935.6, and 963.6 were observed in the mass spectra
(Figure 5A), indicating a difference of m/z 28 between each species. Further, 1H-NMR
and 13C-NMR revealed a signal characteristic of −CH2− groups (1.3 and 30 ppm, respectively),
and indicated the presence of alkyl chains differing (CH2)2 units. Additionally, 1H-NMR
and 13C-NMR provided evidence of the presence of cis and/or trans double bonds (Figures
5B–5D; 1, 2, 3), with the latter possessing an adjacent methyl branch (Figures 5B–5D; 5) and
a keto group (Figures 5C and 5D; 14), suggesting that Lipid-Y was a mixture of cis- and
trans-unsaturated long-chain ketones (Figure 5D). Based on the masses obtained by MALDI-
TOF/MS, these unsaturated, branched ketones were of chain lengths C62, C64, or C66. Since
the accumulation of Lipid-Y was accompanied by a loss of mycolates (and no detectable free
α-alkyl, β-oxo mycolate precursors), it seemed likely that the ketones that comprised Lipid-Y
were derived from free β-oxo precursors. Free α-alkyl, β-oxo mycolate precursors could
undergo decarboxylation to form ketones. If this was the case, then the oxo group would be
situated between alkyl chains that originate from a meroacid on one side and the α branch on
the other. Through the use of electron impact-MS (EI-MS), we were able to confirm the
presence of a fragment of m/z 351, corresponding to the α chain (C22) plus a carbonyl group.
In addition, the detection of fragments of m/z 546, 574, and 602, corresponding to C39, C41,
and C43 monounsaturated alkyl chains, respectively, further substantiated our findings.
Discussion
With the exception of KasB, all enzymes involved in the biosynthesis of mycolic acids in
mycobacterial species are encoded by essential genes (Bhatt et al., 2005; Brown et al., 2007;
Parish et al., 2007; Portevin et al., 2004; Sacco et al., 2007). However, we were able to generate
a viable null mutant of MSMEG4722, the gene that encodes the reductase involved in mycolic
acid motif synthesis in M. smegmatis. This was not entirely surprising, because global
transposon mutagenesis screens predicted insertions in Rv2509, the M. tuberculosis homolog
of MSMEG4722, to result in a slow-growth phenotype. Indeed, the ΔMSMEG4722 mutant did
exhibit a slow growth rate similar to that observed in C. glutamicum (Lea-Smith et al., 2007).
Alkaline hydrolysis of the parental strain M. smegmatis mc2155 released α−, α′− and epoxy
mycolates, as expected, but hydrolyzates of the ΔMSMEG4722 mutant showed no evidence
of mycolates (Figure 3A). Instead, hydrolyzates of the mutant ΔMSMEG4722 showed the
presence of rapidly migrating components (Figures 3A and 3B, labeled “?”). If the
ΔMSMEG4722 mutant was accumulating α-alkyl, β-oxo mycolate precursors, alkaline
hydrolysis would produce unstable β-oxo acids, which would lose carbon dioxide to yield long-
chain ketones. Through an alternative approach, we confirmed the presence of the α-alkyl, β-
oxo fatty acyl precursors by converting them to α-alkyl, β-hydroxy fatty acids (mycolates) by
prior reduction of bound mycolates with NaBH4. This resulted in the appearance of α, α′ and
epoxy-MAMEs in extracts of both whole and delipidated cells from the mutant strain
(Figure 3C).
As expected (Minnikin and Polgar, 1966), reduction of the β-oxo mycolate precursors gave a
mixture of separable diastereoisomers, and the presence of the β-epimer of α-MAME was
clearly seen (MAME-II; Figure 3C). It would be expected that the β-epimers of α′− and epoxy
mycolates would also be produced, but such minor compounds would not be readily seen on
1D-TLC (Figure 3C). The epoxy function is also susceptible to NaBH4 reduction and isomeric
hydroxylated derivatives were identified (MAME-I; Figure 3C), corresponding to two artifacts
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previously characterized in acid methanolysates (Minnikin et al., 1982). However, reduction
of the delipidated cells gave only the most polar hydroxylated derivative (Figure 3C). This
strongly suggests that access of NaBH4 to cell wall-bound epoxy mycolates was restricted. It
has recently been shown that keto mycolates from Mycobacterium bovis BCG adopt a folded
“W” conformation (Villeneuve et al., 2007) with the keto group in a similar hydrophilic
environment as the hydroxy acid unit. It is reasonable to suggest that bound epoxy mycolic
acids might also prefer such a folded “W” conformation that could direct the access of
NaBH4 in a regiospecific manner, resulting in the formation of only a single hydroxylated
derivative. It is notable that the covalently bound β-oxo precursors in the ΔMSMEG4722
mutant also produce only the more polar derivative. This would suggest that β-oxo precursors
also fold in the same way as intact mycolates, indicating that a β-hydroxy group is not an
absolutely essential prerequisite for folding in a “W” conformation. Indeed, the fact that
ΔMSMEG4722 mutant cells are viable, with β-oxo mycolate analogs in their envelopes,
strongly suggests that an exchange of a native β-hydroxy group for an unnatural β-oxo unit is
permitted. However, as discussed later, the ΔMSMEG4722 mutant cells were more permeable
to lipophilic antibiotics, and colony morphology was affected. Further studies will be needed
to clarify these intriguing observations.
Additionally, replacement of TMM and TDM with derivatives with slightly altered TLC
mobility in ΔMSMEG4722 (Figure 4A) suggest that the α-alkyl, β-oxo mycolate precursors
were also esterified to trehalose. Indeed, we obtained similar results for MAME analysis from
extracts of whole cells (which contain wall-bound and trehalose-bound mycolates) as well as
delipidated cells (which contain only wall-bound mycolates), demonstrating that mycolic acids
in both the mAGP complex and in TMM/TDM were replaced by the α-alkyl, β-oxo fatty acid
precursors.
While the loss of the reductase was expected to generate precursors of mycolic acids, it was
surprising that the α-alkyl, β-oxo fatty acids were associated with the cell wall. These data
suggest that mycobacterial components involved in the processing, transport, and subsequent
transfer of mycolic acids to the cell wall (including the hypothetical mycolyl transferases I and
II and the proteins of the antigen 85 complex [Takayama et al., 2005]) were probably able to
do the same with the α-alkyl, β-oxo fatty acid intermediates. In contrast, Lea-Smith et al.
(2007) reported reduced levels of AG-mycolylation in the C. glutamicum reductase mutant
(ΔNCgl2385). Corynomycolate derivatives released from mutant cell wall were distinct from
wild-type corynomycolates, and showed an ∼80% reduction in abundance. However, the
extraction method used in this previous study involved acid-methanolyis. In light of our
findings, it is likely that, rather than a reduction in mycolylation, the ΔNCgl2385 mutant
contained equally abundant α-alkyl, β-oxo corynomycolate precursors esterified to the AG,
which were not detected by GC and MS because of decomposition resulting from acid-
methanolysis.
Incorporation of the α-alkyl, β-oxo fatty acid precursors, instead of mycolic acids in the cell
wall, had a significant impact on the characteristics of the cell wall of M. smegmatis, rendering
the mutant strain more susceptible to lipophilic antibiotics due to an increased permeability.
The presence on a β-oxo rather than a β-hydroxyl group also affected the colony morphology
of the mutant strain, presumably due to changes in the hydrophobicity of the outer surface of
the bacterial cells.
A key distinction between the reductase mutants of C. glutamicum and M. smegmatis was the
accumulation of an unusual lipid, Lipid-Y, in the latter. MS and NMR analyses of purified
Lipid-Y revealed it to be a mixture of unsaturated, branched ketones. Similar ketones were
detected in strains of M. tuberculosis (tuberculenone) and Corynebacterium diptheriae
(Asselineau, 1954; Pudles and Lederer, 1954). The total number of carbons (C60 ± C3) in the
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monounsaturated M. tuberculosis ketone, tuberculenone is similar to those of Lipid-Y (C62–
C66) in the MSMEG4722 mutant. However, tuberculenone was characterized before the advent
of mass spectrometry (Asselineau, 1954), so precise comparisons are not meaningful. It has
been suggested that ketones like tuberculenone are derived from decarboxylation of the α-alkyl,
β-oxo fatty acid intermediates of mycolic acids (Asselineau, 1966). In addition to cell wall-
bound and glycolipid-associated mycolates, mycobacteria also contain free mycolic acids, and
would be expected to contain some transient, unreduced mycolic acid intermediates at any
given time. It is likely that tuberculenone is derived from these intermediates. In the
ΔMSMEG4722 mutant, however, no free mycolic acids were detected (Figure 4C). Instead, an
accumulation of α-alkyl, β-oxo fatty acid intermediates would be expected to occur. Free acids
of such intermediates would then undergo decarboxylation to form the ketones that comprise
Lipid-Y. Through the use of EI-MS, we were able to confirm that this was indeed the case.
Environmental mycobacteria are known to alter cell wall mycolate composition in response to
growth substrates, resulting in a more hydrophobic wall when grown in the presence of
hydrophobic substrates (Wick et al., 2002). It is not clear whether mycolate reduction is
regulated by environmental factors, but our studies here have shown that loss of the β-hydroxy
mycolate motif reduction alters cell wall hydrophobicity. Whether this has an effect in vivo
(in the case of M. tuberculosis) remains to be studied.
In conclusion, our results clearly demonstrate that MSMEG4722 is the reductase involved in
generation of the mycolic acid motif in M. smegmatis. The loss of this function is not lethal,
allowing cell wall incorporation of β-oxo mycolate analogs, but affecting the growth
characteristics of the bacterium.
Significance
Mycolic acid biosynthesis is essential for mycobacterial survival and many
antituberculosis drugs, such as isoniazid, ethionamide, and thiolactomycin, target
enzymes of this exclusive pathway (Banerjee et al., 1994; Kremer et al., 2000).
Interestingly, MSMEG4722, which catalyzes the final step in mycolic acid biosynthesis
in Mycobacterium smegmatis, is nonessential, and α-alkyl, β-oxo mycolate precursors are
attached to arabinogalactan and trehalose. However, we have demonstrated that loss of
function does cause major changes in the cell wall of M. smegmatis, making it more
susceptible to lipophilic antibiotics, such as rifampicin. By extension, loss of Rv2509, the
Mycobacterium tuberculosis homolog, would be expected to have a bearing not only on
susceptibility to antibiotics, but also on virulence, as strains of M. tuberculosis with altered
mycolic acids are highly attenuated (Bhatt et al., 2007; Dubnau et al., 2000; Glickman
et al., 2000), highlighting the potential of Rv2509 as a “secondary” drug target. Our
studies also shed some light on the post-fatty acid synthase-II/Pks13 processing,
transport, and transfer of mycolic acids to their location in the cell envelope. The
replacement of mycolic acids in the cell wall by the α-alkyl, β-oxo fatty acid precursors
suggested that post-Pks13 reduction of the β-oxo group was not necessary for the
subsequent processing pathways.
Experimental Procedures
Bacterial Strains, Phages, Plasmids, and Culture Conditions
All plasmids, phages, and bacterial strains used in this study are shown in Table 2. Strains of
E. coli were cultured in LB (Difco). M. smegmatis strains were grown in either LB broth or
tryptic soy broth (TSB; Difco), each containing 0.05% Tween-80. TSB-agar was prepared by
adding 1.5% agar to TSB prior to autoclaving. For M. smegmatis, hygromycin (100 μg ml−1)
or kanamycin (20 μg ml−1) was used for selection, while hygromycin (150 μg ml−1) or
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kanamycin (40 μg ml−1) was used for selecting recombinant E. coli strains. Determination of
MIC of antibiotics was done in LB with the Alamar blue assay (Franzblau et al., 1998).
Bioinformatics
Sequence alignments were determined with BLAST or EBI ClustalW (Chenna et al., 2003),
and rendered with the EScript 2.2 Web server. Structural predictions were performed with the
@TOME server (Douguet and Labesse, 2001), and modeling performed with the FUGUE Web
server (http://tardis.nibio.go.jp/fugue/align.php). PyMOL (DeLano Scientific) was used to
create POV scenes followed by rendering by POV-Ray.
Construction of a MSMEG4722 Null Mutant
Approximately 1 kb sequences of the upstream and downstream regions of MSMEG4722 were
PCR-amplified from M. smegmatis mc2155 genomic DNA with the primer pairs MS4722LL
(5′-TTTTTTTTCCATAAATTGGTGGCCAGCAGGT AGTAGACG-3′) and MS4722LR (5′-
TTTTTTTTCCATTTCTTGGAGTTCGGTGGCCAACG CTTC-3′), and MS4722RL (5′-
TTTTTTTTCCATAGATTGGTGGATCGACACCGAGTAC AC-3′) and MS4722RR (5′-
TTTTTTTTCCATCTTTTGGAAACTGATCCGCTCCAAGGG-3′), respectively (all primers
had Van91I recognition sites incorporated at the 5′ end). The PCR fragments were digested
with Van91I and directly cloned into Van91I-digested p0004S (gift from T. Hsu and W.R.
Jacobs Jr., Albert Einstein College of Medicine, NY). Recombinant plasmids obtained after
transforming E. coli TOP-10 cells were digested with Van91I for confirmation and sequenced.
One plasmid, pΔMSMEG4722, was linearized by PacI digestion and packaged into the
temperature-sensitive mycobacteriophage phAE159, as previously described (Bardarov et al.,
2002), to yield phasmid DNA of the knockout phage phΔMSMEG4722. Generation of high-
titer phage particles and specialized transduction were performed as described previously
(Bardarov et al., 2002). Allelic exchange in hygromycin-resistant transductants was confirmed
by Southern blot.
Construction of Complemented Strains
MSMEG4722 was PCR amplified from M. smegmatis mc2155 genomic DNA with the primers
MS4722-U (5′-GCAGGATCCAATGAGCCGCATGCCAGTACCCG-3′) and MS4722-D
(5′-GCAGAATTCCTAACCGCCGCCGAGCTTCTTG-3′) and cloned into the E. coli-
Mycobacterium shuttle plasmid pMV261 with the primer-incorporated BamHI and EcoRI
sites, to yield the recombinant plasmid pMV261-MSMEG4722. In a similar fashion, the
plasmid pMV261-Rv2509 was constructed with Rv2509, which was PCR amplified from
M. tuberculosis H37Rv genomic DNA with the primers Rv2509-U (5′-
GCAGGATCCAATGCCGATACCCGCGCCC-3′) and Rv2509-D (5′-
GCAGAATTCCTAGCTGCCCCCAAGCCTC-3′). The complemented strains
ΔMSMEG4722-C and ΔMSMEG4722-CRv were obtained by selecting kanamycin-resistant
transformants following electroporation of the mutant strain ΔMSMEG4722 with pMV261-
MSMEG4722 or pMV261-Rv2509 respectively. Electroporation was performed as previously
described (Snapper et al., 1990).
Lipid and Mycolic Acid Extraction and Analysis
Polar and apolar lipids were extracted from M. smegmatis strains and analyzed as described
previously (Dobson et al., 1985). For extraction of MAMEs, both the delipidated cells and the
whole-cell pellets were subjected to alkaline hydrolysis with 5% aqueous TBAH at 100°C
overnight, followed by the addition of 4 ml CH2Cl2, 500 μl CH3I, 2 ml water, followed by
mixing for 30 min. The upper aqueous phase was discarded following centrifugation, and the
lower organic phase washed thrice with water and evaporated to dryness. The resulting FAMEs
and MAMEs were dissolved in diethyl ether, insoluble residues were removed by
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centrifugation, and the ether solution evaporated to dryness and redissolved in 200 μl of
CH2Cl2. Equivalent volumes of the resulting solution of FAMEs and MAMEs was subjected
to TLC with silica gel plates (5735 silica gel 60F254; Merck, Darmstadt, Germany), developed
in petroleum ether-acetone (95:5). Autoradiograms were produced by overnight exposure of
Kodak X-Omat AR film to the plates to reveal [14C]-labeled FAMEs and MAMEs.
Argentation-TLC was performed as described above after saturation of TLC plates with 10%
aqueous silver nitrate solution and prior activation at 100°C for 1 hr. Lipid-Y was purified by
preparative silica gel TLC with petroleum ether:ethyl acetate (98:2, v/v) and detection by
spraying with ethanolic Rhodamine 6G to visualize the lipid under a 366 nm UV lamp. The
area containing Lipid-Y was removed and extracted from the silica gel with diethyl ether. The
extracted sample was then resolved on a second TLC plate in toluene:acetone (95:5, v/v) and
purified as described above. MALDI-TOF/MS of all samples was performed with the Voyager
DE-STR MALDI-TOF instrument (PerSeptive Biosystems, Framingham, MA). NMR spectra
for Lipid-Y were recorded in CDCl3 on a Bruker DRX500 operating at 500.13 MHz for 1H-
NMR and 125.77 MHz for 13C-NMR.
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Figure 1.
Mycolic Acid Reductases in Mycobacteria
(A) Schematic representation of the post-FAS-II steps in mycobacterial mycolic acid
biosynthesis. AccD4 and AccD5 are acyl-CoA carboxylases, while FadD32 is an acyl-AMP
ligase. It is yet unclear whether the reduction of the β-oxo group occurs while the mycolic acid
precursor in still attached to Pks13, or after release from Pks13 by a thioesterase.
(B) Alignment of amino acid sequences of Rv2509 and MSMEG4722 with 1cyd (PDB file for
the structure of Mus musculus carbonyl reductase with NADP and 2-propanol). α Helices and
β sheets are indicated above the residues as coils and arrows, respectively. Residues essential
for NAD/NADP binding are indicated by triangles, while the active-site residue is indicated
with a star.
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Figure 2.
Generation of a MSMEG4722 Null Mutant
(A) Map of the MSMEG4722 region in the parental M. smegmatis strain mc2155 and its
corresponding region in the ΔMSMEG4722 mutant. res, γδ resolvase site; hyg, hygromycin
resistance gene from Streptomyces hygroscopicus; sacB, sucrose counterselectable gene from
Bacillus subtilis. Digoxigenin-labeled probes were derived from ∼1 kb upstream and
downstream flanking sequences that were used to construct the knockout plasmid, and are
indicated by thick lines with diamond-shaped ends. ClaI-digested bands expected in a Southern
blot are indicated in roman numerals with sizes in parentheses. The inset shows the Southern
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blot of ClaI-digested genomic DNA from the two strains with expected bands indicated by
arrows.
(B) Colonies of wild-type (mc2155), mutant (ΔMSMEG4722), and complemented
(ΔMSMEG4722-C) strains on TSB-agar (−) or TSB-agar + 0.05% Tween-80 (+). Colony
growth shown in upper row was obtained by inoculating 5 μl of a broth culture on the agar
plate, while the lower row shows pictures of a single isolated colony of each strain. Scale bar
= 1 mm.
(C) Growth curve of wild-type (mc2155), mutant (ΔMSMEG4722), and complemented
(ΔMSMEG4722-C) strains in TSB.
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Figure 3.
TLC Analysis of Mycolic Acid Methyl Esters
(A) TLC analysis of MAMEs extracted from mc2155, ΔMSMEG4722, ΔMSMEG4722-C, and
ΔMSMEG4722-CRv strains. The rapidly migrating species observed in ΔMSMEG4722 are
indicated by a question mark. FAMEs, fatty acid methyl esters.
(B) 2D Ag+-TLC of MAMEs extracted from mc2155, ΔMSMEG4722, and ΔMSMEG4722-C.
UFAMEs, unsaturated fatty acid methyl esters.
(C) TLC analysis of MAMEs extracted from cells pretreated with NaBH4.
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Figure 4.
2D-TLC Analysis of Apolar Lipids Extracted from mc2155, ΔMSMEG4722, and
ΔMSMEG4722-CStrains
(A) Direction 1, chloroform:methanol:water, 100:14:0.8 (v/v); direction 2,
chloroform:acetone:methanol:water, 50:60:2.5:3 (v/v). GMM, glucose monomycolate; TDM,
trehalose dimycolate; TMM, trehalose monomycolate.
(B) Direction 1, petroleum ether:acetone, 98:2 (v/v, thrice); direction 2, toluene:acetone, 98:2
(v/v). Lipid-Y is indicated by an arrow and question mark.
(C) Direction 1, chloroform:methanol, 96:4 (v/v); direction 2, toluene:acetone, 80:20 (v/v).
MA, mycolic acids.
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Figure 5.
Structural Analysis of Lipid-Y
(A–D) (A) MALDI-TOF/MS, (B) 1H-NMR, and (C) 13C-NMR of purified Lipid-Y.
Characteristic shifts are labeled as numbers, and the structures they represent are indicated in
(D).
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Table 1
MALDI-TOF/MS Analysis of MAMEs Isolated from Different M. smegmatis
Strains
Total Carbon No. of Mycolic Acid
62 64 74 75 76 77 78 79 80
Untreated
 WT
  α′ 952a 980a
  α 1118 1132 1146 1160a 1174 1188a
  Epoxy 1148 1162 1176a 1190 1204a 1218
NaBH4 treated
 WT
  α′ 952a 980a
  α 1118 1132 1146 1160a 1174 1188a
  Epoxy 1162 1176a 1190 1204a
  Hydroxyl 1178 1206 1220
 ΔMSMEG4722
  α′ 952a 980a
  α 1118 1146 1160a 1188a
  α-epib 1160a 1188a
  Epoxy 1176a 1190
  Hydroxyl 1177
 ΔMSMEG4722-C
  α′ 952a 980a
  α 1118 1132 1146 1160a 1174 1188a
  Epoxy 1162 1176a 1190 1204a
  Hydroxyl 1178 1206 1220
The masses indicated are those of Na adducts.
a
Masses of predominant species.
bα-epi is the isomer of α-mycolates.
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Table 2
Plasmids, Bacterial Strains, and Phages Used in This Study
Description Reference/Source
Plasmids
 pMV261 E. coli-Mycobacterium shuttle plasmid vector with hsp60 promoter
and KanR cassette (aph)
Stover et al. (1991)
 pMV261-MSMEG4722 MSMEG4722 cloned in pMV261 This work
 pMV261-Rv2509 Rv2509 cloned in pMV261 This work
 p0004s Vector for cloning allelic-exchange substrates to be used for
specialized transduction; contains λ phage cos site and HygR
cassette (hyg)
Gift from T. Hsu and W.R. Jacobs,
Jr., Albert Einstein College of
Medicine, New York
 pΔMSMEG4722 Derivative of p0004s designed for allelic exchange of M. smegmatis
MSMEG4722
This work
Bacterial strains
 mc2155 Electroporation-proficient ept mutant of M. smegmatis strain mc26 Snapper et al. (1990)
 ΔMSMEG4722 Deletion mutant of mc2155 in which MSMEG4722 is replaced by
hyg
This work
 ΔMSMEG4722-C Complemented strain of ΔMSMEG4722 containing pMV261-
MSMEG4722
This work
 ΔMSMEG4722-CRv Complemented strain of ΔMSMEG4722 containing pMV261-
Rv2509
This work
Phages
 phAE159 Conditionally replicating shuttle phasmid derived from the lytic
mycobacteriophage TM4
Bardarov et al. (2002)
 phΔMSMEG4722 Derivative of phAE159 obtained by cloning pΔMSMEG4722 into
its unique PacI site
This work
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